Effect of Coffeeberry on Mood and Cognitive Performance
NCT ID: NCT04975802
Last Updated: 2022-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2021-07-05
2022-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Coffeeberry on Mood, Motivation and Cognitive Performance
NCT04974606
The Effects of a Single Dose of Wild Blueberries on Mood and Cognition in Healthy Young Adults
NCT04935099
Effect of Date Seeds Coffee on Mood and Cognitive Performance
NCT04009564
Acute Effects of Mango Leaf Extract on Cognitive Function in Healthy Adults: A Double-Blind, Placebo-Controlled Crossover Study
NCT05182450
Plant Based Extracts and Cognition
NCT02202629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0 mg coffeeberry beverage
Appearance-matched to the other products
Placebo
10 oz (296 ml) cherry flavored still beverage
100 mg coffeeberry beverage
Appearance-matched to the other products
Coffeeberry
10 oz (296 ml) cherry flavored still beverage
300 mg coffeeberry beverage
Appearance-matched to the other products
Coffeeberry
10 oz (296 ml) cherry flavored still beverage
75 mg caffeine beverage
Appearance-matched to the other products
Caffeine
10 oz (296 ml) cherry flavored still beverage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
10 oz (296 ml) cherry flavored still beverage
Coffeeberry
10 oz (296 ml) cherry flavored still beverage
Caffeine
10 oz (296 ml) cherry flavored still beverage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants self-report that they are in good health
* Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial
* Willing to abstain from consumption of caffeine within 12 h of testing
* Willing to abstain from alcohol consumption and avoid vigorous physical activity for 24 h prior to all test visits
* Willing to refrain from 'over the counter' medications (e.g. pain medication) and stimulant medication for 12 hours, seasonal allergy/hay fever nasal antihistamine medications for 24 hours and oral antihistamines for 48 hours prior to all test visits
* Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study Investigator.
* Current use of prescription medication, except for contraceptives
* Report hypersensitivity to caffeine
* Major trauma or major surgical event within 6 months of screening
* Extreme dietary habits, as judged by the Investigator (high fat, very high protein diets, intermittent fasting, etc.)
* Exposure to coffeeberry within 30 d prior to screening
* History of cancer in the prior two years, except for non-melanoma skin cancer
* Have a visual impairment that cannot be corrected with glasses or contact lenses
* Food allergies/intolerances/sensitivities to any ingredients in the study products (including coffee or related foods/beverages/products)
* Self-report excessive leisure time physical activity (\> 7 strenuous bouts per week)
* Have a current or chronic gastrointestinal, sleep, or psychiatric disorders
* Work night shifts or follow a variable work pattern that results in irregular sleep pattern
* Are pregnant, trying to get pregnant or lactating
* Smoke tobacco, vape nicotine or use nicotine replacement products
* Use illegal/recreational drugs
* Unable to demonstrate adequate minimal performance on lab, computer-based cognitive tasks
* Have participated in another clinical trial within past 30 days and/or participation in another PepsiCo trial in the past 6 months
* Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg)
* Have a Body Mass Index (BMI) outside of the range 18.5-35 kg/m2
* Have learning and/or behavioural disorders such as dyslexia or ADHD
* Excessive caffeine intake (\>500 mg per day)
* Have taken dietary supplements e.g. Vitamins, omega 3 fish oils etc. in the last 4 weeks (Note: participation is possible following a 4 week supplement washout prior to participating and for the duration of the study on the proviso that the supplements they are taking are out of choice and not medically prescribed or advised)
* Have any health condition that would prevent fulfilment of the study requirements (this includes non-diagnosed conditions for which no medication may be taken)
* Has been diagnosed with/ undergoing treatment for alcohol or drug abuse in the last 12 months
* Have been diagnosed with/ undergoing treatment for a psychiatric disorder in the last 12 months
* Suffers from frequent migraines that require medication (more than or equal to 1 per month)
* Any known active infections
* Does not have a bank account (required for payment)
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PepsiCo Global R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippa Jackson, PhD
Role: PRINCIPAL_INVESTIGATOR
Northumbria University Newcastle, UK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brain, Performance and Nutrition Research Centre Northumbria University
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEP-2005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.